Logo image of EGIO

EDGIO INC (EGIO) Stock Fundamental Analysis

NASDAQ:EGIO - Nasdaq - US53261M2035 - Common Stock - Currency: USD

1.11  -0.27 (-19.57%)

After market: 1.0496 -0.06 (-5.44%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to EGIO. EGIO was compared to 82 industry peers in the IT Services industry. Both the profitability and financial health of EGIO have multiple concerns. EGIO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

EGIO had negative earnings in the past year.
EGIO had a negative operating cash flow in the past year.
EGIO had negative earnings in 4 of the past 5 years.
EGIO had a positive operating cash flow in 4 of the past 5 years.
EGIO Yearly Net Income VS EBIT VS OCF VS FCFEGIO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -33.85%, EGIO is doing worse than 86.75% of the companies in the same industry.
EGIO has a Return On Equity of -99.89%. This is in the lower half of the industry: EGIO underperforms 74.70% of its industry peers.
Industry RankSector Rank
ROA -33.85%
ROE -99.89%
ROIC N/A
ROA(3y)-17.23%
ROA(5y)-10.88%
ROE(3y)-38.66%
ROE(5y)-23.93%
ROIC(3y)N/A
ROIC(5y)N/A
EGIO Yearly ROA, ROE, ROICEGIO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -20 -40

1.3 Margins

Looking at the Gross Margin, with a value of 29.13%, EGIO is doing worse than 66.27% of the companies in the same industry.
EGIO's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for EGIO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.6%
GM growth 5Y-7.61%
EGIO Yearly Profit, Operating, Gross MarginsEGIO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 20 -20 40 -40

More info and screens

1

2. Health

2.1 Basic Checks

EGIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EGIO has been increased compared to 1 year ago.
Compared to 1 year ago, EGIO has an improved debt to assets ratio.
EGIO Yearly Shares OutstandingEGIO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 1M 2M 3M 4M 5M
EGIO Yearly Total Debt VS Total AssetsEGIO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of -2.18, we must say that EGIO is in the distress zone and has some risk of bankruptcy.
EGIO has a worse Altman-Z score (-2.18) than 86.75% of its industry peers.
A Debt/Equity ratio of 0.89 indicates that EGIO is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.89, EGIO is doing worse than 63.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z -2.18
ROIC/WACCN/A
WACC3.38%
EGIO Yearly LT Debt VS Equity VS FCFEGIO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 0.85 indicates that EGIO may have some problems paying its short term obligations.
With a Current ratio value of 0.85, EGIO is not doing good in the industry: 79.52% of the companies in the same industry are doing better.
EGIO has a Quick Ratio of 0.85. This is a bad value and indicates that EGIO is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.85, EGIO is not doing good in the industry: 79.52% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.85
EGIO Yearly Current Assets VS Current LiabilitesEGIO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for EGIO have decreased strongly by -33866.67% in the last year.
EGIO shows a strong growth in Revenue. In the last year, the Revenue has grown by 37.59%.
EGIO shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.93% yearly.
EPS 1Y (TTM)-33866.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3400%
Revenue 1Y (TTM)37.59%
Revenue growth 3Y19.06%
Revenue growth 5Y12.93%
Sales Q2Q%-12.45%

3.2 Future

Based on estimates for the next years, EGIO will show a very strong growth in Earnings Per Share. The EPS will grow by 118.32% on average per year.
EGIO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.99% yearly.
EPS Next Y-4320%
EPS Next 2Y-390.68%
EPS Next 3Y106.46%
EPS Next 5Y118.32%
Revenue Next Year8.61%
Revenue Next 2Y4.75%
Revenue Next 3Y8.35%
Revenue Next 5Y9.99%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EGIO Yearly Revenue VS EstimatesEGIO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M
EGIO Yearly EPS VS EstimatesEGIO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 -5 10 -10 15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

EGIO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EGIO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EGIO Price Earnings VS Forward Price EarningsEGIO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EGIO Per share dataEGIO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

EGIO's earnings are expected to grow with 106.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-390.68%
EPS Next 3Y106.46%

More info and screens

0

5. Dividend

5.1 Amount

EGIO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EDGIO INC

NASDAQ:EGIO (9/17/2024, 8:02:28 PM)

After market: 1.0496 -0.06 (-5.44%)

1.11

-0.27 (-19.57%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)04-25 2024-04-25/amc
Earnings (Next)10-17 2024-10-17/amc
Inst Owners0.02%
Inst Owner Change-2.63%
Ins Owners118.55%
Ins Owner Change0%
Market Cap6.50M
Analysts45.71
Price Target30.6 (2656.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.92%
Min EPS beat(2)2.79%
Max EPS beat(2)19.05%
EPS beat(4)3
Avg EPS beat(4)-12.91%
Min EPS beat(4)-90.08%
Max EPS beat(4)19.05%
EPS beat(8)5
Avg EPS beat(8)31.31%
EPS beat(12)5
Avg EPS beat(12)-26.93%
EPS beat(16)8
Avg EPS beat(16)-1.13%
Revenue beat(2)0
Avg Revenue beat(2)-1.34%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)-1.2%
Revenue beat(4)0
Avg Revenue beat(4)-6.58%
Min Revenue beat(4)-23.22%
Max Revenue beat(4)-0.42%
Revenue beat(8)0
Avg Revenue beat(8)-8.58%
Revenue beat(12)0
Avg Revenue beat(12)-8.9%
Revenue beat(16)2
Avg Revenue beat(16)-6.58%
PT rev (1m)34.33%
PT rev (3m)34.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.9%
EPS NY rev (1m)0%
EPS NY rev (3m)1.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF N/A
P/OCF N/A
P/B 0.04
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-10.19
EYN/A
EPS(NY)-5.78
Fwd EYN/A
FCF(TTM)-8.69
FCFYN/A
OCF(TTM)-6.65
OCFYN/A
SpS64.83
BVpS26.21
TBVpS-15.45
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -33.85%
ROE -99.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.13%
FCFM N/A
ROA(3y)-17.23%
ROA(5y)-10.88%
ROE(3y)-38.66%
ROE(5y)-23.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.6%
GM growth 5Y-7.61%
F-Score2
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 30.49%
Cap/Sales 3.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.85
Quick Ratio 0.85
Altman-Z -2.18
F-Score2
WACC3.38%
ROIC/WACCN/A
Cap/Depr(3y)94.14%
Cap/Depr(5y)108.41%
Cap/Sales(3y)11.25%
Cap/Sales(5y)11.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33866.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3400%
EPS Next Y-4320%
EPS Next 2Y-390.68%
EPS Next 3Y106.46%
EPS Next 5Y118.32%
Revenue 1Y (TTM)37.59%
Revenue growth 3Y19.06%
Revenue growth 5Y12.93%
Sales Q2Q%-12.45%
Revenue Next Year8.61%
Revenue Next 2Y4.75%
Revenue Next 3Y8.35%
Revenue Next 5Y9.99%
EBIT growth 1Y-75.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year14.19%
EBIT Next 3Y40.08%
EBIT Next 5Y32.04%
FCF growth 1Y-113.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-494.67%
OCF growth 3YN/A
OCF growth 5YN/A